Guide to OCD Symptoms Types and Treatment Options

Share this post:

LinkedIn
Facebook
X
Reddit
WhatsApp
Print

Obsessive compulsive disorder, or OCD, is a long lasting mental health disorder marked by intrusive recurring thoughts, urges, or mental images called obsessions and repetitive actions or mental rituals called compulsions. These symptoms can take up large parts of your day, create strong distress, and interfere with work, school, relationships and routine tasks. Effective treatment exists, and the main first line options are exposure and response prevention therapy, cognitive behavioral therapy and medication, often used together.

If you are trying to figure out what OCD means in real life, the clearest answer is this. Your mind throws out a threat, doubt, image, urge, or fear that feels urgent and deeply important. You then feel driven to do something to reduce the distress. That action may be visible, such as checking a lock or washing your hands, or hidden, such as reviewing your memory, repeating phrases in your mind, seeking reassurance, or mentally canceling a feared thought. Relief follows for a short time, then the cycle starts again.

OCD is common enough that most clinicians see it regularly. In the United States, an estimated 1.2 percent of adults had OCD in the past year, and lifetime prevalence has been estimated at 2.3 percent. Among adults who had OCD in the past year, about half were rated as having serious impairment. That helps explain why this condition can affect jobs, education, relationships and daily functioning so sharply when symptoms go untreated.

Symptoms often begin between late childhood and young adulthood, though people can notice signs earlier or later. Many adults can tell their fears or rituals do not make logical sense, yet still feel unable to stop. Children may have more trouble spotting that the pattern is excessive and may act from a raw fear that something terrible will happen if they do not complete the ritual.

A full evaluation matters because OCD can look like generalized anxiety, panic, depression, perfectionism, tic disorders, eating disorders, trauma related conditions, psychosis or simple habit patterns from a distance. The details make the diagnosis. In OCD, the intrusive content is recurrent, unwanted and tied to repetitive efforts to reduce distress or prevent a feared outcome. Clinicians also look at how much time the symptoms take, how much they interfere with your life and which rituals happen in public or in private.

Recognizing the cycle of obsessions and compulsions

The core OCD loop usually starts with an obsession. That obsession may be a fear of contamination, a fear that you caused harm, a sexual or violent image, a doubt about your relationship, a religious fear, a need for symmetry, or a worry that you forgot something important. The obsession creates distress, guilt, disgust, dread, or a raw sense that something is off. You then perform a compulsion to reduce that feeling or to prevent a feared event. The compulsion brings short relief, which teaches your brain to use the ritual again the next time the fear appears.

This loop can get stronger over time because the ritual blocks a deeper lesson. Your brain does not get enough time to learn that the fear can rise, peak and fall on its own. It also does not learn that uncertainty can be tolerated without checking, washing, confessing, arranging, counting, praying, or reviewing. That is why OCD can expand from one trigger to many. A ritual that starts with one doorknob can spread to groceries, packages, clothing, money, phones and entire rooms.

What obsessions often feel like

Obsessions are not just worries. They are intrusive and sticky. They can feel vivid, repetitive and hard to dismiss. You may feel shock, disgust, shame, panic, guilt, or a sense of moral danger the moment they appear. Common obsession themes include fear of germs or contamination, fear of forgetting or losing something, fear of losing control over your behavior, aggressive thoughts toward yourself or others, unwanted sexual or religious thoughts and a strong need for things to feel exact, orderly or symmetrical.

One reason OCD is so exhausting is that the content often attacks what you care about most. If you care deeply about safety, your obsessions may center on harm. If you care about loyalty, your mind may attack your relationship. If faith matters to you, religious obsessions may take over. If being a careful parent or partner feels central to your identity, your mind may produce repeated doubt about mistakes, contamination, honesty, attraction or risk. OCD often uses that personal value system to create urgency.

What compulsions often look like

Compulsions can be physical acts, mental acts, or both. Common visible rituals include handwashing, cleaning, checking doors, stoves, appliances and messages, arranging objects, touching things a set number of times, or redoing tasks until they feel right. Common hidden rituals include counting, praying, repeating words silently, reviewing memories, scanning your feelings for certainty, mentally testing attraction, seeking reassurance and trying to neutralize a thought with another thought.

That hidden side is one reason OCD can stay undetected for years. Someone around you may see only indecision, lateness, avoidance, irritability, repeated questions, or overpreparation. They may not see the mental checking, silent repetition, or internal debate happening every few minutes. A person can look outwardly calm and still be caught in a long internal ritual.

Relief keeps the disorder going

Compulsions are driven by relief. They often do not feel pleasant. People with OCD usually do not perform rituals for enjoyment. They perform them because the discomfort feels unbearable or because the feared outcome feels too dangerous to leave alone. After the ritual, the fear drops for a short time. That short drop teaches the brain that the ritual worked, which makes the urge to repeat it even stronger later.

This same pattern applies to reassurance seeking and avoidance. If you repeatedly ask a loved one if everything is okay, ask a clinician for repeated certainty, search the internet for the same symptom every night, avoid knives, avoid public bathrooms, avoid driving, or avoid your partner during a wave of intrusive doubt, the short relief can keep the disorder active. OCD often grows through small habits that seem sensible in the moment.

Signs that the pattern has crossed into OCD

A diagnosis does not rest on one thought or one habit. Many people have passing intrusive thoughts. Many people also like order, routine, cleanliness and caution. OCD is more likely when obsessions or compulsions take more than an hour a day, create significant distress, interfere with normal functioning, or pull you into repeated rituals you feel unable to resist. Another clue is that compulsions usually bring temporary relief from anxiety rather than pleasure.

Some people also have tics, depression, panic, social anxiety, or other anxiety disorders alongside OCD. That overlap can blur the picture and delay diagnosis. A careful assessment can sort out which symptoms belong to OCD, which belong to another condition and which issues need treatment at the same time.

The most common subtypes you need to know

Clinicians often use the word subtype as shorthand for common symptom patterns. These patterns can look very different on the surface, but they share the same basic engine of obsession, distress and compulsion. The diagnosis remains OCD unless another condition in the obsessive compulsive and related disorders group fits better. That group also includes hoarding disorder, body dysmorphic disorder, hair pulling disorder, skin picking disorder and olfactory reference disorder, which are separate diagnoses with their own features.

Contamination OCD

Contamination OCD often centers on germs, illness, chemicals, bodily fluids, dirt, sticky substances, public surfaces, food safety, or a sense that a person, object, place, or word has become contaminated. The response often includes washing, showering, cleaning, laundering, changing clothes, avoiding physical contact, throwing away items, or creating strict rules about what can touch what. Some people fear actual disease. Others fear an internal feeling of dirtiness or moral contamination that is harder to explain.

This subtype can become severe because everyday life involves constant contact with triggers. You may spend long periods cleaning your home, redoing showers, sanitizing packages, or avoiding objects other people touch without concern. Work routines, family life and intimacy can all shrink as the circle of “safe” items grows smaller.

Checking OCD

Checking OCD usually grows out of fear of harm, fear of mistakes, fear of leaving something unfinished, or fear that you are responsible for a disaster. You may repeatedly check locks, appliances, brakes, paperwork, emails, bags, medications, children, or your own memory. Many people with this pattern feel an intense sense of responsibility and a deep fear that one missed detail could ruin a life.

The checking rarely brings lasting certainty. Instead, repeated checking can make memory feel less reliable. After the fifth or tenth check, your brain may stop storing the event clearly because the action has become repetitive and automatic. That can leave you feeling even less certain than before, which drives more checking.

Symmetry, order and “just right” OCD

Some people are consumed by the need for symmetry, exactness, balance, evenness, or a “just right” feeling. They may line up objects, arrange items by size or color, repeat actions until both sides of the body feel even, or restart tasks when something feels incomplete. Others count steps, taps, or words and feel strong tension until the number comes out correctly.

This pattern can look like perfectionism from a distance, but the lived experience is usually more severe. The drive is often physical and urgent. You may feel a surge of tension, inner friction, or mental alarm until the arrangement feels correct. That tension can hold up dressing, writing, cooking, leaving the house and finishing simple tasks.

Harm OCD

Harm related OCD often involves intrusive fears or images about causing injury to yourself or others. The content may involve stabbing, poisoning, running someone over, pushing someone, making a dangerous mistake, or losing control in a sudden moment. These thoughts can feel horrifying, especially because they go directly against your values. People with this pattern often avoid sharp objects, avoid driving, avoid cooking, avoid being alone with children, or repeatedly seek proof that they are safe people.

A key clinical point is that intrusive harm thoughts in OCD are ego dystonic. They feel unwanted and alarming. The person is distressed by them and tries to prevent harm, often through avoidance or rituals. That is part of why assessment by a trained clinician matters. The content can sound shocking, but the full pattern usually shows fear, overcontrol and repeated attempts to gain certainty or safety.

Sexual, religious and other taboo thought OCD

Many people with OCD have intrusive content about sex, religion, morality, blasphemy, cheating, orientation, consent, or inappropriate behavior. These obsessions can involve mental images, urges, phrases, fears of saying something offensive, or repeated doubt about what you meant, felt, intended, or believed. Compulsions may include silent prayer, confession, mental reviewing, checking bodily sensations, avoiding media, avoiding people, or repeatedly asking for reassurance.

This theme often stays hidden because shame is strong and people fear being judged. That delay can be costly. When the thoughts stay secret, the person may think they are the only one with such content and may try to suppress the thoughts harder. Suppression usually increases the sense that the thought is dangerous and important, which feeds the loop.

Pure obsessional presentations

Some people use the label Pure O to describe OCD that seems to involve only intrusive thoughts. In practice, mental compulsions are often present even when outward rituals are hard to spot. Reviewing events, checking arousal, testing feelings, praying, canceling thoughts, repeating phrases and seeking hidden certainty can all function as compulsions. That is why a careful history has to include internal rituals, not just visible behavior.

Hoarding and related conditions

Because hoarding sits in the same broader diagnostic family, many people assume it is simply a type of OCD. Current diagnostic systems treat hoarding disorder as a separate condition. The same is true for body dysmorphic disorder, hair pulling disorder and skin picking disorder. Symptoms can overlap and some people have more than one diagnosis, but accurate naming still matters because treatment plans can differ.

Standard therapies and daily management techniques

The two main treatment categories for OCD are psychotherapy and medication. The most studied therapy approach is cognitive behavioral therapy that includes exposure and response prevention, usually called ERP. Medication often involves selective serotonin reuptake inhibitors, or SSRIs. Many people do best with a mix of both, especially when symptoms are moderate to severe or have been present for a long time.

Exposure and response prevention

ERP is the core behavioral treatment for OCD. In ERP, you face feared situations, thoughts, images, objects, or memories in a planned way while resisting the ritual that usually follows. The exposure can be external, such as touching a surface you fear is dirty, or internal, such as intentionally bringing a feared thought to mind. The response prevention part means you do not wash, check, confess, neutralize, ask for reassurance, or perform the mental ritual that usually follows.

This process works by changing learning over time. When you stay with the trigger and do not ritualize, your brain has a chance to learn that anxiety can rise and fall without the compulsion. You also get repeated practice living with uncertainty. That is important because certainty seeking is one of OCD’s strongest fuels. Treatment usually starts with easier items and builds toward harder ones, with homework between sessions.

ERP is demanding. It asks you to face exactly what your brain wants to escape. That is part of why skilled guidance matters. A therapist with OCD training can help design exposures that match your symptom pattern, cut out hidden rituals and keep the work focused on learning rather than white knuckling.

Cognitive behavioral therapy

CBT gives you a broader frame for spotting distorted threat estimates, inflated responsibility, compulsive doubt and rigid rules about certainty, morality and control. In OCD care, CBT is usually paired with ERP rather than used as a purely insight based talk approach. The best results often come when your thoughts, physical sensations and rituals are mapped together and turned into a practical treatment plan.

Medication options

SSRIs are the main medication class used for OCD. These medicines can reduce the intensity of obsessions and compulsions and make ERP more manageable. Common options used in OCD care include fluoxetine, sertraline, escitalopram, fluvoxamine and paroxetine. Clomipramine, an older serotonin reuptake inhibitor, is also effective and may be considered in some cases.

Medication for OCD often takes longer to show benefit than many people expect. Improvement may take 8 to 12 weeks, and OCD often requires higher doses than are commonly used for depression. That time frame matters because people sometimes stop too early and assume the medication failed when the trial was incomplete. Medication changes should always be made with a licensed prescriber because abrupt stopping can cause withdrawal symptoms or return of symptoms.

Medication can also cause side effects such as headaches, nausea, agitation, sleep problems, dizziness, bowel changes and sexual side effects. Some people tolerate one SSRI better than another. That is one reason treatment may involve dose changes, a switch within the same class, or a move to clomipramine under careful supervision.

Daily management techniques that support treatment

Daily management does not replace treatment, but it can help you get more from it. One useful skill is naming the pattern fast. When an obsession appears, it helps to identify it as an OCD trigger rather than entering a long debate with the thought. The point is to stop treating every intrusive event like an emergency.

A second skill is delaying the ritual. You may not be able to stop every compulsion at once. Even a short delay can help weaken the automatic link between distress and ritual. During that delay, focus on staying present rather than proving safety. You are practicing tolerance of uncertainty and discomfort.

A third skill is cutting reassurance seeking. Repeated questions such as “Are you sure I did not offend them,” “Do you think this means something,” or “Can you check this one more time” may feel harmless, but they can keep symptoms active. Family members often need guidance here because helping with rituals can become a routine response to distress. In OCD care, loved ones are usually encouraged to support treatment without joining rituals or helping avoidance.

Sleep, alcohol use, stress and general overload can also affect symptom intensity. Many people notice that OCD gets louder during periods of strain. That does not create OCD by itself, but it can make intrusive thoughts more frequent and rituals harder to resist. A steady routine, reduced alcohol or drug use, better sleep and fewer self imposed trigger tests can make treatment easier to carry out.

Journaling can help when it is used to track patterns, triggers and rituals. It can backfire when it becomes another form of checking or confession. The same is true for meditation, breathing exercises and mindfulness tools. They can help you stay with discomfort during ERP, but they become compulsive if you use them every time to “cancel” a thought or force a feeling of certainty. The key question is simple. Are you using the tool to stay present, or to neutralize the obsession right away.

What treatment progress often looks like

Progress in OCD treatment rarely feels dramatic day to day. More often, you notice that triggers take less time, rituals happen less often, recovery after a spike is faster and life gets wider again. You can leave the house faster. You ask fewer repeated questions. You tolerate uncertainty a little longer. You stop arranging your day around rituals. Those shifts are often more meaningful than a complete absence of intrusive thoughts, since intrusive thoughts can still occur in people who are improving.

When traditional medicine fails to provide relief

Some people do not improve enough with a first round of therapy or the first medication they try. That does not mean the condition is untreatable. It often means the diagnosis needs review, the therapy needs stronger OCD specific work, the medication trial needs more time or dose adjustment, hidden rituals are still active, or another condition is complicating the picture.

One common problem is treatment mismatch. General talk therapy can help with many forms of distress, but OCD usually needs direct exposure work and ritual reduction. A person may spend months discussing fears without doing systematic ERP. They may gain insight into the problem and still remain stuck in the same ritual loop. When care becomes more OCD specific, results often improve.

Another issue is that many rituals are hidden. A person may stop visible washing or checking yet continue mental reviewing, self monitoring, silent prayer, internet research, reassurance seeking, or avoidance of subtle triggers. Those covert rituals can keep symptoms active even when therapy appears to be moving forward. That is why experienced OCD care pays close attention to mental compulsions and avoidance patterns.

When one SSRI does not help enough, clinicians may switch to another SSRI or use clomipramine in selected cases. Some patients with persistent symptoms may also receive augmentation with another medication under specialist care. Those decisions depend on symptom severity, side effect burden, other diagnoses and how complete the earlier trials were.

More intensive forms of behavioral care can also help. Some people need a longer course of ERP, more sessions per week, intensive outpatient treatment, or residential treatment when symptoms are severe enough to dominate daily life. This is especially relevant when someone cannot consistently carry out exposures at home, has severe avoidance, or is spending many hours per day in rituals.

For severe OCD that remains active after standard care, transcranial magnetic stimulation may be considered. TMS is a noninvasive treatment that uses magnetic stimulation to target specific brain circuits. It is generally used after first line treatment such as ERP and medication have already been tried, and it is often used as an add on rather than a stand alone replacement for therapy.

Deep brain stimulation is another option for very severe cases. DBS is a surgical treatment that places electrodes in specific brain areas and delivers electrical pulses. Federal agencies note that it is used for severe OCD after other treatments have not worked, and it remains a highly specialized intervention. In the United States, its use in OCD has been allowed under a Humanitarian Device Exemption for severe cases.

If you reach this stage of care, a full reassessment is often useful. Clinicians may review the original diagnosis, look for tic disorders, depression, trauma related symptoms, substance use, autism spectrum features, eating disorder symptoms, bipolar features, psychotic symptoms, or medical issues that could alter the treatment plan. They may also look closely at family accommodation, sleep patterns and the exact situations where rituals remain strongest.

The biggest practical point is that a stalled first treatment does not define the outcome. OCD can be stubborn. It can also respond when the diagnosis is sharpened, ERP becomes more direct, medication trials are completed properly, or advanced care is brought in at the right time.

Conclusion

As treatment paths continue to develop, we at Rose Hill Life Sciences study specific therapeutic pathways for severe mental loops through the production and research of Psilocybe cubensis, operating at the intersection of science and therapeutic integration, and are based in Massachusetts.

Disclaimer: The information in this article is for educational and informational purposes only and does not constitute medical advice.

You May Also Like

Adam Goodman

Advisor

Adam is a seasoned entrepreneur with a wealth of experience in spearheading real estate development and management endeavors. His focus primarily lies in land development, where he orchestrates the intricate tapestry of planning and zoning entitlements, while meticulously overseeing all facets of engineering and architectural design, leasing, construction, and financing.

With a national reach spanning 23 states and encompassing over 250 properties, totaling more than 6 million square feet, Adam’s proficiency in navigating the complexities of the industry is evident.

Beyond real estate, Adam’s endeavors extend into the realm of alternative investments, boasting successful ventures in healthcare, professional sports franchises, financial services, diverse agricultural platforms, and the stewardship of local restaurants.

 

Rotem Petranker, PhD, Psychology

Psychedelic Researcher

Rotem Petranker is a psychedelics researcher with a particular emphasis on microdosing, therapy, research methods and research ethics. He earned his BSc from the University of Toronto, his Master’s degree from York University, and his PhD from McMaster University.

As part of my research, I have gained extensive expertise in navigating the regulatory landscapes of Health Canada and the FDA and a strong background in designing rigorous clinical trial research methodologies. 

I founded the Canadian Centre for Psychedelic Science in 2018, established the Psychedelic Science Research Program at the University of Toronto in 2019, and, more recently, ran the largest clinical trial to date on the effectiveness of microdosing psilocybin for Major Depressive Disorders. I have published many papers on microdosing, including some of the largest samples in the literature and some that have set standards for performing psychedelic research.

Kevin Bourke

Chief Commercial Officer

Kevin Bourke is a dynamic executive and strategic planner whose career spans over two decades of crafting and elevating world-class Jamaican brands and transformational experiences on the global stage. With a keen understanding of culture, identity, and international markets, he has played a pivotal role in shaping some of Jamaica’s most iconic names — including Appleton Estate Rum, Chris Blackwell’s Rum, and Usain Bolt’s Tracks & Records — bringing them from local roots to international acclaim. His leadership and vision have also been instrumental in major cultural movements such as Fiction and the internationally recognized TmrwTday Wellness Festival.

An innovator at heart, Mr. Bourke seamlessly blends brand strategy with deep cultural resonance. His ability to connect with diverse audiences has established these brands not only as commercial successes but as symbolic ambassadors of Jamaican excellence, fortifying the island’s influence in beverage, music, lifestyle, and experiential sectors.

In recent years, Kevin has steered his strategic acumen toward the cutting-edge psilocybin and wellness industry, becoming a co-founder and Chief Marketing and Branding Officer of Rose Hill, Jamaica’s leading cultivator, exporter, and innovator of psilocybin products and experiences. Through ventures like ONE Retreats, he has helped craft safe, guided psychedelic-assisted healing programs that attract participants from around the world seeking deep personal transformation, including military veterans and international wellness seekers.

Kevin’s impact extends beyond business into industry shaping and policy, as he sits on the Jamaica Psilocybin Mushroom Industry Technical Committee (under the Bureau of Standards) — a pivotal body that is formalizing guidelines and regulatory standards for the emerging legal psilocybin sector in Jamaica. His presence on this committee underscores his leadership role in ensuring the industry’s integrity, safety, and sustainable growth.

Highly regarded for his extensive network throughout Jamaica and internationally, Kevin remains passionately committed to advancing ethical, high-integrity product development and customer-centric experiences at every level. His dedication is driven not only by professional achievement but by a deep vision for human well-being, cultural celebration, and the global evolution of plant-based healing.

Jama Pitman

Regulatory Strategy

Jama Pitman is a seasoned biopharmaceutical executive with extensive expertise in global drug development and commercialization. With over two decades of experience, she has contributed to the development of groundbreaking therapies across oncology, rare diseases, and antivirals. As a strategic leader, she has successfully transitioned companies from private to public markets, navigated complex M&A transactions, and driven innovative drug approvals.

Jama has held executive roles in leading organizations, including Deciphera Pharmaceuticals, where she played a pivotal role in scaling operations from a small, privately held biotech company to a global, multi-product company acquired for $2.4 billion. She brings exceptional skills in regulatory affairs, portfolio management, quality assurance, and clinical operations, longside a proven track record of fostering inclusivity and mentorship within her teams.

Currently, as the founder of JP BioPharma Consulting, Jama advises biopharma and tech companies on accelerating drug development and achieving corporate goals. Her collaborative and forward-thinking approach aligns seamlessly with Rose Hill’s mission to advance transformative therapies in mental health and beyond.

Education: B.Sc. in Microbiology, University of New Hampshire.

Notable Achievements: Contributed to the development of multiple FDA-approved therapies, including QINLOCK® for gastrointestinal stromal tumors.

Domenic Suppa

Chief Operating Officer

Domenic is co-founder and the Operations Chief of Rose Hill Health Holdings.

He has been working as a Cannabis technology and operations veteran with more than 11 years’ experience as a senior executive in an operationally complex, and highly regulated industry.

His introduction and entrance into the Cannabis sector started in 2010 with a seed investment into a Denver-based vertically integrated cannabis company called, Evolab. He served as C.O.O. for 5 years from 2013-2018, through the eventual acquisition by Harvest Health and Recreation (HARV: CSE).

Domenic moved on to be acting COO of the manufacturing division for Supreme Cannabis (CSE: FIRE) and supported the acquisition of BLISSCO (CSE: BLISS, a BC-based cannabis manufacturer). Domenic has worked with high-profile national cannabis brands including KKE, and Monogram, and retail brands in MA Native Sun, Terps, and Tilt. Domenic is a proven leader and team builder; his previous experiences have all been with early-stage and growth equity enterprises.

He has refined and evolved his leadership roles, including his team-building skills. He is a value creator. Domenic is a firm believer in training and continuous development. He excels in employing practices, tools, and methodologies designed to achieve maximum process efficiency while minimizing waste and delays.

 

Burton J. Tabaac

Clinical Development

Dr. Burton J. Tabaac, MD, FAHA, brings a wealth of expertise in neurology and stroke rehabilitation to Rose Hill. As an Associate Professor and Section Chief of Neurology at The University of Nevada’s Reno School of Medicine, and Medical Director of Stroke at Carson Tahoe Health, Dr. Tabaac has been at the forefront of innovative neurological treatments.

A graduate of the prestigious cerebrovascular neurology fellowship program at The Johns Hopkins University Hospital, Dr. Tabaac’s accolades include being a three-time recipient of The Arnold P. Gold Foundation’s Humanism and Excellence in Teaching Award and induction into the Alpha Omega Alpha Honor Medical Society.

He recently published an eight-part paper in the American Journal of Therapeutics reviewing psychedelics as therapeutics for primary care clinicians. Dr. Tabaac’s groundbreaking research focuses on the application of psychedelics in brain injury and stroke rehabilitation.

Dr. Tabaac was recently appointed by the Governor of Nevada to serve as a member of the state’s Psychedelic Medicines Working Group, which provides expertise and testimony relating to the therapeutic use of entheogens.

As the host of The Zero Hour Podcast, he engages with leading experts in psychedelic research. His commitment to advancing the field was further highlighted in his 2022 TEDx talk at UCLA, “Mental Health Meets Psychedelics.”

“Joining Rose Hill’s advisory team presents an exciting opportunity to further explore the potential of psilocybin in neurological recovery,” said Dr. Tabaac.

“The company’s commitment to ethical cultivation and research aligns perfectly with my vision for advancing patient care through innovative therapies. I’m eager to bring my expertise to Rose Hill and contribute to the evolving landscape of psychedelic medicine.”

Charles Lazarus

Chief Executive Office

Mr. Lazarus boasts over 16 years of extensive expertise in psilocybin and cannabis, focusing on genetic development, cultivation, extraction, and operations logistics. Notably, he recently achieved a milestone by cultivating and delivering the largest legal shipment of premium psilocybin globally.

As an accomplished owner/operator, Mr. Lazarus has successfully managed multiple farming and harvesting businesses, earning commendations for his unwavering commitment to quality and impressive output volumes. Since 2015, he has been actively involved in producing proprietary psilocybin genetics and cultivation solutions tailored for the Jamaican market and large research and development clients.

His contributions span various aspects, including genetic development, cultivation, extraction, harvest, and logistics. Additionally, Mr. Lazarus owned and operated Island Fresh Ltd., a venture that played a pivotal role in exporting fresh fruit, ground provisions, and promoting brand Jamaica to the English market. Under his leadership, Island Fresh Ltd. achieved the highest volume from Jamaica for three consecutive years.

Mr. Lazarus’s extensive experience also includes serving as the Harvest Manager for cannabis grow operations in California from 2013 to 2017, further solidifying his comprehensive knowledge in the cannabis industry.